Display options
Cite
Aso E, Andrés-Benito P, Grau-Escolano J, et al. Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model. Cannabis Cannabinoid Res. 2020;5(2):150-163doi: 10.1089/can.2019.0005.
Aso, E., Andrés-Benito, P., Grau-Escolano, J., Caltana, L., Brusco, A., Sanz, P., & Ferrer, I. (2020). Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model. Cannabis and cannabinoid research, 5(2), 150-163. https://doi.org/10.1089/can.2019.0005
Aso, Ester, et al. "Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model." Cannabis and cannabinoid research vol. 5,2 (2020): 150-163. doi: https://doi.org/10.1089/can.2019.0005
Aso E, Andrés-Benito P, Grau-Escolano J, Caltana L, Brusco A, Sanz P, Ferrer I. Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model. Cannabis Cannabinoid Res. 2020 Jun 05;5(2):150-163. doi: 10.1089/can.2019.0005. eCollection 2020 Jun 01. PMID: 32656347; PMCID: PMC7347043.
Copy Download .nbib Format: NLM
Share it on

Cannabis Cannabinoid Res. 2020 Jun 05;5(2):150-163. doi: 10.1089/can.2019.0005. eCollection 2020 Jun 01.

Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model.

Cannabis and cannabinoid research

Ester Aso, Pol Andrés-Benito, Jordi Grau-Escolano, Laura Caltana, Alicia Brusco, Pascual Sanz, Isidre Ferrer

Affiliations

  1. Unitat de Farmacologia, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina i Ciències de la Salut, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.
  2. Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.
  3. CIBERNED, Centro de Investigación Biomédica en Red de En.fermedades Neurodegenerativas, Instituto Carlos III, Madrid, Spain.
  4. Unitat de Anatomia Patològica, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.
  5. Instituto de Biología Celular y Neurociencia Prof. E. de Robertis (IBCN, UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
  6. Instituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Científicas (IBV-CSIC), Valencia, Spain.
  7. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Group U742, Valencia, Spain.

PMID: 32656347 PMCID: PMC7347043 DOI: 10.1089/can.2019.0005

[No abstract available.]

Copyright 2020, Mary Ann Liebert, Inc., publishers.

Keywords: Lafora disease; cannabidiol; cannabinoids; epilepsy; neurodegeneration

Conflict of interest statement

No competing financial interests exist.

References

  1. Brain Behav Immun. 2019 Feb;76:165-181 - PubMed
  2. Epileptic Disord. 2016 Sep 1;18(S2):38-62 - PubMed
  3. Br J Clin Pharmacol. 2013 Feb;75(2):323-33 - PubMed
  4. Epilepsy Behav. 2017 May;70(Pt B):319-327 - PubMed
  5. Lancet Neurol. 2016 Mar;15(3):270-8 - PubMed
  6. Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11229-11234 - PubMed
  7. CNS Drugs. 2019 Jan;33(1):47-60 - PubMed
  8. Hum Mol Genet. 2012 Apr 1;21(7):1521-33 - PubMed
  9. Mol Neurobiol. 2016 Mar;53(2):1296-1309 - PubMed
  10. Cannabis Cannabinoid Res. 2017 Jan 01;2(1):8-20 - PubMed
  11. CNS Neurosci Ther. 2011 Dec;17(6):637-44 - PubMed
  12. Bioorg Med Chem. 2015 Apr 1;23(7):1377-85 - PubMed
  13. Lancet Neurol. 2005 Apr;4(4):239-48 - PubMed
  14. Mol Neurobiol. 2017 Jul;54(5):3119-3130 - PubMed
  15. Hum Mol Genet. 2002 May 15;11(11):1251-62 - PubMed
  16. Hum Mol Genet. 2018 Apr 1;27(7):1290-1300 - PubMed
  17. Biochem Pharmacol. 2018 Nov;157:210-216 - PubMed
  18. PLoS One. 2014 Apr 21;9(4):e95922 - PubMed
  19. J Neurosci. 2011 Apr 27;31(17):6329-38 - PubMed
  20. Biochem Pharmacol. 2018 Nov;157:67-84 - PubMed
  21. Pharmacol Rev. 2010 Dec;62(4):588-631 - PubMed
  22. Epilepsia. 2014 Jun;55(6):791-802 - PubMed

Publication Types

Grant support